Thursday, September 24, 2015 12:38:43 PM
by john murphy
Chart shows Biotech iShares (IBB) falling back below its 200-day average.
Its relative strength line (top of chart) has turned down as well.
Biotech selling has hurt the Nasdaq market as well as the healthcare sector, which is the day's weakest sector.
Chart shows Biotech iShares (IBB) falling back below its 200-day average.
Its relative strength line (top of chart) has turned down as well.
Biotech selling has hurt the Nasdaq market as well as the healthcare sector, which is the day's weakest sector.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
